摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-{3-[4-(1-hydroxy-1-methyl-2-oxopropyl)-phenoxy]-2(R)-hydroxypropoxy}-benzyl)tetrahydro-2-furancarboxylic acid | 499788-89-5

分子结构分类

中文名称
——
中文别名
——
英文名称
2-(3-{3-[4-(1-hydroxy-1-methyl-2-oxopropyl)-phenoxy]-2(R)-hydroxypropoxy}-benzyl)tetrahydro-2-furancarboxylic acid
英文别名
2-[[3-[(2S)-2-hydroxy-3-[4-(2-hydroxy-3-oxobutan-2-yl)phenoxy]propoxy]phenyl]methyl]oxolane-2-carboxylic acid
2-(3-{3-[4-(1-hydroxy-1-methyl-2-oxopropyl)-phenoxy]-2(R)-hydroxypropoxy}-benzyl)tetrahydro-2-furancarboxylic acid化学式
CAS
499788-89-5
化学式
C25H30O8
mdl
——
分子量
458.508
InChiKey
IYNOCRRFKKDUTE-LXKSKSEUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    33
  • 可旋转键数:
    11
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    123
  • 氢给体数:
    3
  • 氢受体数:
    8

文献信息

  • Cyclic compound and ppar agonist
    申请人:Clark Richard
    公开号:US20050014833A1
    公开(公告)日:2005-01-20
    The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R 1 to R 6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A 1 and A 2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: represents a single bond or a double bond; X represents a single bond, an oxygen atom, —NR X1 CQ 1 O—, etc.; Y represents Y 1 —Y 2 — (wherein Y 1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y 2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
    本发明提供了一种具有出色PPAR激动剂作用的新化合物。更具体地说,它提供了一种由以下公式表示的化合物,其盐,酯或合物。其中a,b和c彼此相同或不同,每个表示0到4; R1至R6彼此相同或不同,每个表示氢原子,羟基,基,卤素原子等; A1和A2彼此相同或不同,每个表示单键,氧原子等; L,M和T每个表示单键,具有一到六个碳原子的烷基等; W表示羧基;由以下公式表示的部分结构:表示单键或双键; X表示单键,氧原子,-NRX1CQ1O-等; Y表示Y1-Y2-(其中Y1表示具有一到四个取代基的5到14个成员的芳香环等; Y2表示单键或5到14个成员的芳香环); 而环Z表示从上述A族中选择的具有一到四个取代基的5到14个成员的芳香环,可以具有一个或多个杂原子,并且可以部分饱和。
  • CYCLIC COMPOUND AND PPAR AGONIST
    申请人:Eisai Co., Ltd.
    公开号:EP1452521A1
    公开(公告)日:2004-09-01
    The present invention provides a novel compound having an excellent PPAR agonist action. More specifically, it provides a compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. Wherein a, b and c are the same as or different from one another and each represents 0 to 4; R1 to R6 are the same as or different from one another and each represents a hydrogen atom, a hydroxyl group, a cyano group, a halogen atom, etc.; A1 and A2 are the same as or different from each other and each represents a single bond, an oxygen atom, etc.; L, M and T each represent a single bond, an alkylene group having one to six carbon atoms, etc.; W represents a carboxyl group; the partial structure represented by the formula: ------¯ represents a single bond or a double bond; X represents a single bond, an oxygen atom, -NRX1CQ1O-, etc.; Y represents Y1-Y2- (wherein Y1 represents a 5 to 14-membered aromatic ring having one to four substituents, etc.; and Y2 represents a single bond or a 5 to 14-membered aromatic ring); and the ring Z represents a 5 to 14-membered aromatic ring which have one to four substituents selected form the above-mentioned Group A, may have one or more hetero atoms and may be partially saturated.
    本发明提供了一种具有优异 PPAR 激动剂作用的新型化合物。更具体地说,它提供了由下式代表的化合物、其盐、其酯或它们的合物。 其中 a、b 和 c 彼此相同或不同,各自代表 0 至 4;R1 至 R6 彼此相同或不同,各自代表氢原子、羟基、基、卤素原子等; A1 和 A2 彼此相同或不同,各自代表单键、氧原子等; L、M 和 T 各自代表单键、具有 1 至 6 个碳原子的亚烷基等; W 代表羧基; 式所代表的部分结构: ------¯ 代表单键或双键; X 代表单键、氧原子、-NRX1CQ1O- 等; Y 代表 Y1-Y2-(其中 Y1 代表具有 1 至 4 个取代基的 5 至 14 元芳香环等;Y2 代表单键或 5 至 14 元芳香环);以及 环 Z 代表 5 至 14 元芳香环,该环具有 1 至 4 个从上述 A 组中选出的取代基,可具有一个或多个杂原子,并可部分饱和。
  • US7371777B2
    申请人:——
    公开号:US7371777B2
    公开(公告)日:2008-05-13
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯